The main department of described Corporate Investor is located in the Seoul. The company was established in Asia in South Korea.
We can highlight the next thriving fund investment areas, such as Biotechnology, Supply Chain Management. The fund has no exact preference in some founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight ImpriMed, Luxstay. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Nextrans, startups are often financed by Plug and Play, Pear Ventures, Genesia Ventures. The meaningful sponsors for the fund in investment in the same round are Bon Angels Venture Partners, Y1 Ventures, Viet Capital Ventures. In the next rounds fund is usually obtained by CyberAgent Capital, Bon Angels Venture Partners, Y1 Ventures.
The typical startup value when the investment from Nextrans is 1-5 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 1 - 5 millions dollars. The top activity for fund was in 2018.
|01 Feb 2016||United States, Chicago|
|01 Apr 2020||China, Shanghai|
|2M||21 Mar 2018||United States, Chicago|
|1M||18 Sep 2018||United States, Chicago|
|4M||17 Sep 2018||United States, Chicago|
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.